RVF MP-12
Phase 2Biologic
RVF MP-12 is one of 3 biologic programs targeting Rift Valley Fever. It is currently in Phase 2.
1
Indications
2
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Rift Valley Fever
#DrugCompanyPhaseTrials
1Rabies Vaccine
NovartisPhase 2
RVF MP-12
UU.S. Army Medical Research and Development Command
Phase 2
Chadox1 LS2
EEuBiologics Co.,Ltd
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for RVF MP-12. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details